MGB-BP-3
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MGB-BP-3, covering 2016-03-17 to 2020-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD [Phase 2]